Malignant hyperthermia
Excellence and Credentialing in Health Care · 2026
DOI: 10.1097/echc.0000000000000033 ↗Kurz gefasst
Fachartikel in der Zeitschrift Excellence and Credentialing in Health Care, 2026. Verfasst von Sharon Ann Van Wicklin. Die Arbeit nennt 6 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Purpose
To review the pathophysiology, risk factors, clinical manifestations, and management of malignant hyperthermia (MH) while emphasizing the importance of facility preparedness, interprofessional collaboration, competency validation, simulation-based training, and quality improvement across the surgical continuum. Materials and methods: Current literature and guidance from the Malignant Hyperthermia Association of the United States (MHAUS) and other authoritative sources were reviewed to summarize evidence-based recommendations related to MH recognition, treatment, preparedness, and competency assessment. As a narrative review, this article is intended to provide a practical overview of current evidence and recommendations related to MH preparedness and management; therefore, it does not employ the systematic search and appraisal methods used in systematic reviews or meta-analyses.
Results
MH is a rare but potentially fatal pharmacogenetic disorder characterized by a hypermetabolic response to triggering anesthetic agents. Although advances in monitoring, treatment, and education have reduced mortality, successful outcomes continue to depend on early recognition and immediate intervention. Effective management requires prompt discontinuation of triggering agents, administration of dantrolene sodium, aggressive supportive care, and coordinated interprofessional teamwork. Because MH is a low-frequency, high-acuity event, preparedness efforts should include readily accessible emergency medications and equipment, anesthesia machine preparation protocols, simulation-based training, competency validation, mock drills, and ongoing evaluation of organizational readiness.
Conclusions
Despite its rarity, MH remains a significant perioperative patient safety concern. Ongoing professional education, competency assessment, interdisciplinary collaboration, and quality improvement initiatives are essential to maintaining preparedness and supporting timely, effective management when an MH crisis occurs.
Zitieren
APA
Wicklin, S. A. V. (2026). Malignant hyperthermia. Excellence and Credentialing in Health Care. https://doi.org/10.1097/echc.0000000000000033
Vancouver
Wicklin SAV. Malignant hyperthermia. Excellence and Credentialing in Health Care. 2026. doi:10.1097/echc.0000000000000033
BibTeX
@article{Wicklin2026,
author = {Wicklin, Sharon Ann Van},
title = {Malignant hyperthermia},
journal = {Excellence and Credentialing in Health Care},
year = {2026},
doi = {10.1097/echc.0000000000000033}
}
EUVIMED